Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.

Abroad (travel likely)Recruiting

Conditions

Leukemia · Lymphoma · Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Centre Hospitalier Amiens-Picardie, Amiens, France
Contact: Study coordinator (Delphine LEBON, PhD) · lebon.delphine@chu-amiens.fr · 03 22 45 59 14
Centre Hospitalier Universitaire d'Angers, Angers, France
Contact: Study coordinator (Corentin Orvain, PhD) · corentin.orvain@chu-angers.fr · 02 41 35 44 75
Centre Hospitalier Universitaire Besancon, Besançon, France
Contact: Study coordinator (Yohan Desbrosses, PhD) · ydesbrosses@chu-besancon.fr · 03 81 66 82 32
Centre Hospitalier Universitaire Brest, Brest, France
Contact: Study coordinator (Marie-Anne Couturier, PhD) · marie-anne.couturier@chu-brest.fr · 02 98 22 30 37
Centre Hospitalier universitaire Nancy, Nancy, France
Contact: Study coordinator (Caroline Bonmati, PhD) · c.bonmati@chru-nancy.fr · 03 83 15 32 82
Centre Hospitalier Universitaire Nantes, Nantes, France
Contact: Study coordinator (Pierre Peterlin, PhD) · pierre.peterlin@chu-nantes.fr · 02 40 08 32 71
Centre Hospitalier Universitaire poitiers, Poitiers, France
Contact: Study coordinator (Maria-Pilar Gallego-Hernanz, PhD) · maria-pilar@gallego-hernanz@chupoitiers.fr · 05 49 44 43 07
centre Hospitalier Universitaire Saint etienne, Saint-Etienne, France
Contact: Study coordinator (Emmanuelle Tavernier, PhD) · Emmanuelle.Tavernier@chu-stetienne.fr · 04 77 91 70 60
centre Hospitalier Universitaire Strasbourg, Strasbourg, France
Contact: Study coordinator (Célestine Simand, PhD) · c.simand@icans.eu · 03 68 76 74 07
centre Hospitalier Universitaire Tours, Tours, France
Contact: Study coordinator (Alban Villate, PhD) · a.villate@chu-tours.fr · 02 47 47 37 12

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Acute Myeloid Leukemia in Remission · Myelodysplastic Syndromes · Chronic Myeloid Leukemia in Remission

Abroad (travel likely)RecruitingPHASE2

Antwerp, Belgium · Bruges, Belgium

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

Recurrent Chronic Lymphocytic Leukemia · Recurrent Small Lymphocytic Lymphoma · Refractory Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children

Adrenal Insufficiency · Leukemia, Lymphoblastic, Acute, Pediatric · Lymphoma, Lymphoblastic

Abroad (travel likely)Recruiting

Aarau, Switzerland · Basel, Switzerland

Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families

Leukemia · Non Hodgkin Lymphoma

Abroad (travel likely)Recruiting

Aurora, United States